Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

NCT06101823 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: OpSCF
BIOLOGICAL: Placebo
BIOLOGICAL: OpSCF (Open Label Extension)

Sponsor

Opsidio, LLC

Collaborators

[object Object]